ÂÜÀòÂÒÂ×

Thomas Langenickel, MD, has more than 15 years of experience in clinical development and translational medicine in cardiovascular and respiratory disease areas. He previously held the position of Executive Director and Head of Respiratory Profiling at Novartis AG and served as Medical Director at Bristol-Myers Squibb. He obtained his MD and PhD at the Humboldt University of Berlin, trained in Clinical Pharmacology and Internal Medicine/Cardiology at the Max-Delbrück Center for Molecular Medicine and the Charité Hospital in Berlin, Germany. He previously completed a post-doctoral fellowship at the National Heart, Lung and Blood Institute in Bethesda, USA.